EUVIMEDEUVIMED entdecken
Crossref

INTELLECTUAL CAPITAL TERHADAP KINERJA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2009–2017

Christina Agusta, Wirawan E.D. Radianto

Media Akuntansi dan Perpajakan Indonesia · 2020

DOI: 10.37715/mapi.v1i1.1399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Media Akuntansi dan Perpajakan Indonesia, 2020. Verfasst von Christina Agusta und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This purpose of this research is to analyze the impact of intellectualcapital on the companies performance. The research used quantitativeapproach, and it collected by annual reports to pharmaceutical company atIndonesia Stock Exchange (IDX) from year 2009–2017 which had a populationof 10 companies. The hypothesis of this research is tested by usingmultiple regression analysis. The result indicate that (1) intellectual capitalhas positive influence to the companies performance (ROA and ROE); (2)intellectual capital has negative influence on companies performance (ATOand MBV). Hence, to maximize the performance on pharmaceutical companiesmerely consider intellectual capital factors.

Zitieren

APA

Agusta, C., & Radianto, W. E. (2020). INTELLECTUAL CAPITAL TERHADAP KINERJA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2009–2017. Media Akuntansi dan Perpajakan Indonesia. https://doi.org/10.37715/mapi.v1i1.1399

Vancouver

Agusta C, Radianto WE. INTELLECTUAL CAPITAL TERHADAP KINERJA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2009–2017. Media Akuntansi dan Perpajakan Indonesia. 2020. doi:10.37715/mapi.v1i1.1399

BibTeX
@article{Agusta2020,
  author = {Agusta, Christina and Radianto, Wirawan E.D.},
  title = {INTELLECTUAL CAPITAL TERHADAP KINERJA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2009–2017},
  journal = {Media Akuntansi dan Perpajakan Indonesia},
  year = {2020},
  doi = {10.37715/mapi.v1i1.1399}
}
Kostenlos starten →